@FiercePharma: Google near $500M settlement in pharmacy probe. News | Follow @FiercePharma
> Amylin Pharmaceuticals sued its longtime diabetes-drug partner Eli Lilly, saying the larger drugmaker breached their alliance by teaming up with Boehringer Ingelheim on a rival product. Report
> GlaxoSmithKline is now working with UNICEF to enable retrospective publication of the prices it charges the health program, as well as disclosure of future prices. Item
> Alexion Pharmaceutical is expanding its manufacturing plant in Rhode Island, a move expected to add 35 percent more jobs to its current employment of 125 there. News
> Biogen Idec said Australian regulators approved marketing of its multiple sclerosis drug Fampyra. Story
> AstraZeneca purchased for cancellation 334,454 ordinary shares at a price of 3199 pence per share. Article
> Merck South Africa, a subsidiary of Germany's Merck KGaA, has sold its manufacturing to a local private equity firm as part of its ongoing plan to streamline production at facilities around the world. Report
> South Africa's Aspen Pharmacare is working with the Johannesburg-area health department to resolve delays of several months of payments for its supply of AIDS drugs. Item
> U.K. Prime Minister David Cameron will say he is pressing ahead with an overhaul of the state-run National Health Service, rebutting political criticism and attacks from the medical profession. Article
> Dr. Reddy's Laboratories is looking to acquire medicine brands in Russia, CFO Umang Vohra said. Report
> The UK's pharma industry association the ABPI and its biotech equivalent the BIA are jointly relocating to new London offices. Report
> Investors in Alexion Pharmaceuticals approved a 2-for-1 stock split, taking the number of shares to 290 million. Story
Biotech News
@FierceBiotech: iPierian fires top execs, shifts focus. News | Follow @FierceBiotech
@JohnCFierce: Bloomberg's Langreth covers the growing number of cancer drugs in the pipeline which rely on epigenetics. Story Follow @JohnCFierce
> Analysis: Big Pharma is backing out of more biotech deals. Article
> Novartis delivers promising Ph3 data for combo COPD treatment. Item
> Sanofi forges $663M MS antibody development pact with Glenmark. Report
> PacBio's Schadt leading $100M effort at Mt. Sinai. News
> Metabolon plots fast growth as biomarker biz booms. Item
Biotech IT News
> PerkinElmer acquires Labtronics, buyouts pile up. News
> Scientists mount computer-aided attack on H1N1 flu virus. Report
> Sequencing DNA is cheap, analysis not so much. Item
> My visit to Nimbus, Bill Gates' bet on virtual drug discovery. Article
Medical Device News
> Neuronetics completes Series E, raises $30M. Story
> Stryker to buy Orthovita for $304M. Report
> Report: EU needs to do more to ensure device safety. Article
> Varian Medical grabs $15M stake and buyout option from Augmenix. News
> Harmac to create 100 jobs in Ireland. Item
> Sorensen named head of Siemens Healthcare in U.S., Canada. Article
And Finally... Scientists have for the first time confirmed a specific genetic link to depression, according to new evidence published in the American Journal of Psychiatry. Report